Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $7.73 in the prior trading day, Sana Biotechnology Inc (NASDAQ: SANA) closed at $7.61, down -1.55%. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 3.38 million shares were traded. SANA stock price reached its highest trading level at $7.84 during the session, while it also had its lowest trading level at $7.25.
Ratios:
Our goal is to gain a better understanding of SANA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.31 and its Current Ratio is at 3.31. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.32.
On September 25, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $9.
On September 05, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $8.Citigroup initiated its Buy rating on September 05, 2023, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 08 ’24 when Yang Patrick Y sold 25,000 shares for $9.45 per share. The transaction valued at 236,300 led to the insider holds 149,250 shares of the business.
NELSEN ROBERT bought 1,818,181 shares of SANA for $9,999,996 on Feb 08 ’24. The Director now owns 12,446,022 shares after completing the transaction at $5.50 per share. On Feb 08 ’24, another insider, ARCH Venture Fund X, L.P., who serves as the 10% Owner of the company, bought 1,818,181 shares for $5.50 each. As a result, the insider paid 9,999,996 and bolstered with 12,446,022 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 1677609344 and an Enterprise Value of 1576506880.
Stock Price History:
The Beta on a monthly basis for SANA is 1.70, which has changed by 0.5129224 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is -13.70%, while the 200-Day Moving Average is calculated to be 32.82%.
Shares Statistics:
The stock has traded on average 2.01M shares per day over the past 3-months and 1486460 shares per day over the last 10 days, according to various share statistics. A total of 197.86M shares are outstanding, with a floating share count of 122.54M. Insiders hold about 44.41% of the company’s shares, while institutions hold 40.59% stake in the company. Shares short for SANA as of 1711584000 were 26130177 with a Short Ratio of 12.98, compared to 1709164800 on 21054146. Therefore, it implies a Short% of Shares Outstanding of 26130177 and a Short% of Float of 21.55.
Earnings Estimates
Sana Biotechnology Inc (SANA) is presently subject to a detailed evaluation by 4 analysts, each offering their unique perspectives on its market standing.On average, analysts expect EPS of -$0.32 for the current quarter, with a high estimate of -$0.25 and a low estimate of -$0.43, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.22 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$0.93 and -$1.76 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$1.37, with 4 analysts recommending between -$0.92 and -$1.97.
